Skip to main content

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Business HighlightsContinued progress was made in processing Tau proteoform samples from collaborators in support of our goals of product validation and growing our publications. We expect to share this data at the upcoming World HUPO conference. Further progress was made in the development of a new broadscale assay format, which is intended to support our forthcoming commercial launch in late 2026. We expect to launch our early access program with Tau proteoforms in the first half of 2026.“In Q3, Nautilus maintained disciplined execution and delivered meaningful...

Continue reading

CTS Announces Third Quarter 2025 Results

Momentum on Diversification and Solid Execution LISLE, Ill., Oct. 28, 2025 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced third quarter 2025 results. “Our business had another quarter of strong growth with sales up 22% year over year in the diversified end markets. The CTS team executed well in a challenging environment achieving solid profitability and strong cash generation,” said Kieran O’Sullivan, CEO of CTS Corporation. “Diversification remains a strategic priority to drive growth and margin expansion.” Third Quarter 2025 ResultsSales were $143 million in the third quarter of 2025, up 8% year-over-year. Sales to diversified end markets increased 22%. Sales to the transportation end market decreased 7%. Net...

Continue reading

Uni-Fuels Announces 2025 Interim Financial Results

Strong Operational Performance Drives Revenue and Gross Profit Growth SINGAPORE, Oct. 28, 2025 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced its interim financial results for the six months ended June 30, 2025. Key Strategic Developments        On February 12, 2025, the Company’s wholly owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), received ISCC EU and ISCC PLUS certifications from the International Sustainability and Carbon Certification (“ISCC”). The ISCC certifications ensure that the biofuels traded by Uni-Fuels Singapore meet the requirements of the European Union’s (“EU”) Renewable Energy Directive (“RED II”), including the provision of Proof of Sustainability (“POS”). On April...

Continue reading

Franklin Electric Reports Third Quarter 2025 Results

Third Quarter 2025 HighlightsConsolidated net sales of $581.7 million, an increase of 9% to the prior year Net sales increased across all three segments; 11% in Water Systems, 15% in Energy Systems, and 3% in Distribution Operating income was $85.1 million, an increase of 16% to the prior year, with operating margin of 14.6% The company terminated its US Pension Plan for a pre-tax settlement charge of $55.3 million ($41.7 million net of tax) and an EPS impact of approximately $0.93 per share net of tax GAAP fully diluted earnings per share (EPS) was $0.37FORT WAYNE, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. today announced its third quarter financial results for fiscal year 2025. Third quarter 2025 net sales were $581.7 million compared to third quarter 2024 net sales of $531.4 million. Third quarter...

Continue reading

Skyline Bankshares, Inc. Announces Third Quarter 2025 Results

FLOYD, Va. and INDEPENDENCE, Va., Oct. 28, 2025 (GLOBE NEWSWIRE) — Skyline Bankshares, Inc. (the “Company”) (OTC QX: SLBK) – the holding company for Skyline National Bank (the “Bank”) – announced its results of operations for the third quarter of 2025. The Company recorded net income of $4.1 million, or $0.73 per share, for the quarter ended September 30, 2025, compared to net income of $3.8 million, or $0.68 per share, for the second quarter of 2025 and net income of $1.1 million, or $0.19 per share, for the third quarter of 2024. For the nine months ended September 30, 2025, net income was $11.5 million, or $2.05 per share, compared to net income of $4.9 million, or $0.89 per share, for the nine months ended September 30, 2024. Third quarter 2025 earnings represented an annualized return on average assets (“ROAA”) of 1.25% and...

Continue reading

TeraWulf Reports Preliminary Third Quarter 2025 Financial Results

Strong year-over-year growth reflects strategic repositioning to HPC hosting and continued growth momentum EASTON, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced preliminary financial results for the third quarter ended September 30, 2025. The Company expects revenue for the third quarter of 2025 to be between $48 million and $52 million, representing an approximate 84% increase compared to the $27 million reported in the third quarter of 2024. The Company also expects to report adjusted EBITDA of between $15 million and $19 million, versus $6 million in the third quarter of 2024. Leadership Commentary “Our preliminary results reflect continued strength in our operating performance...

Continue reading

Sysco Reports First Quarter 2026 Results; Reiterates FY26 Guidance

HOUSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week first fiscal quarter ended September 27, 2025. Key financial results for the first quarter of fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):Sales increased 3.2%; U.S. Foodservice volume increased 0.1%; Gross profit increased 3.9% to $3.9 billion; Operating income decreased 1.0% to $800 million, and adjusted operating income increased 2.9% to $898 million1; Net earnings decreased 2.9% to $476 million, and adjusted net earnings increased 2.0% to $551 million1; EBITDA decreased 3.1% to $1.0 billion2, and adjusted EBITDA increased 0.1% to $1.1 billion1,2; and EPS3 remained flat at $0.99, and adjusted EPS1 increased 5.5% to $1.15.“We...

Continue reading

Independent Bank Corporation Reports 2025 Third Quarter Results

Third Quarter Highlights Highlights for the third quarter of 2025 include:Increase in net interest income of $0.7 million (or 1.7%) over the second quarter of 2025; Increase in tangible common equity per share of common stock of $1.06 (or 20.0% annualized) from June 30, 2025; Net growth in total deposits, less brokered time deposits of $148.2 million (or 13.0% annualized) from June 30, 2025; Net growth in loans of $33.9 million (or 3.2% annualized) from June 30, 2025; and The payment of a 26 cent per share dividend on common stock on August 15, 2025.GRAND RAPIDS, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP) reported third quarter 2025 net income of $17.5 million, or $0.84 per diluted share, versus net income of $13.8 million, or $0.65 per diluted share, in the prior-year period. William...

Continue reading

Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 – $675 million –– KPL-387 granted Orphan Drug Designation for the treatment of pericarditis – – Cash balance increased by $44.3 million in Q3 2025 to $352.1 million – – Conference call and webcast scheduled for 8:30 am ET today – LONDON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications, today reported third quarter 2025 financial results and recent portfolio execution. “Year to date, ARCALYST revenue has continued to grow, with the expanding adoption of IL-1α...

Continue reading

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchises Orders increased sequentially and greater than 20% year-over-year Increasing revenue guidance to a range of $729 to $737 million, which represents 14% -15.5% year-over-year non-COVID organic growthWALTHAM, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2025, covering the three- and nine- month periods ended September 30, 2025. Provided in this press release are financial performance highlights, updates to our guidance for the full year 2025 and access information for today’s webcast and conference call. Olivier Loeillot, President...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.